RT @vanGilsLab: This HIV ConM SOSIP stabilized trimer has now moved into clinical trials and we hope to have the first results in 2020 @eav…
RT @vanGilsLab: This HIV ConM SOSIP stabilized trimer has now moved into clinical trials and we hope to have the first results in 2020 @eav…
RT @Virus_Evolution: Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence. https://t.co…
RT @vanGilsLab: This HIV ConM SOSIP stabilized trimer has now moved into clinical trials and we hope to have the first results in 2020 @eav…
RT @vanGilsLab: This HIV ConM SOSIP stabilized trimer has now moved into clinical trials and we hope to have the first results in 2020 @eav…
Great work from Kwinten, Ilja and Rogier from @amsterdamumc in collaboration with @scrippsresearch @WardLab1
This HIV ConM SOSIP stabilized trimer has now moved into clinical trials and we hope to have the first results in 2020 @eavi2020 @amsterdamumc #HIVvaccine #ConMSOSIP #ACTHIVE001
RT @Virus_Evolution: Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence. https://t.co…
RT @Virus_Evolution: Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence. https://t.co…
RT @Virus_Evolution: Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence. https://t.co…
RT @Virus_Evolution: Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence. https://t.co…
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence. https://t.co/2OSzQbkPMi https://t.co/gGzX9sh3pP
RT @vaxresearch: Congrats to the EAVI2020 team (https://t.co/8CxbjOJsWj) on our recent publication in Nature Communications on a “ConM” imm…
RT @vaxresearch: Congrats to the EAVI2020 team (https://t.co/8CxbjOJsWj) on our recent publication in Nature Communications on a “ConM” imm…
Congrats to the EAVI2020 team (https://t.co/8CxbjOJsWj) on our recent publication in Nature Communications on a “ConM” immunogen against HIV-1 (https://t.co/VeH5va6Zw2)! This follows work from our team on a “ConS” immunogen (https://t.co/DMq6XDnJ5q), pub
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence. https://t.co/iB6espUePZ
RT @BehavEcolPapers: Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence https://t.co/…
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence https://t.co/QM2kMcnnQz @NatureComms https://t.co/UXf8vLY4gS